Announcements Trials
Browse Landscape

Phase

Phase NA 6Phase 3 2Phase EARLY_PHASE1 1Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Depression 1Breast Neoplasms 1Body Weight Changes 1

Interventions

Cisplatin 1041Cyclophosphamide 973Carboplatin 954Radiotherapy 893Bevacizumab 847Gemcitabine 817pembrolizumab 759Paclitaxel 738Docetaxel 734Oxaliplatin 706Capecitabine 648Fluorouracil 564Rituximab 559Nivolumab 506Dexamethasone 487Etoposide 468Doxorubicin 458Irinotecan 442Drug Therapy 402Leucovorin 377Cytarabine 342Cetuximab 340Lenalidomide 326Trastuzumab 323Pemetrexed 315durvalumab 295Filgrastim 287Magnetic Resonance Spectroscopy 278Temozolomide 275Prednisone 273

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × OTHER × Diet, Fat-Restricted × Clear all
NCT00068458 2017-12-19

Survival TRaining for ENhancing Total Health (STRENGTH)

Duke University

Phase 2 Completed
39 enrolled
Breast

Body Weight Changes, Breast Neoplasms, Depression

Data powered by HemOnc (CC BY 4.0) Colophon âš¡